Status:
UNKNOWN
Transcranial Direct Current Stimulation as an Augmenting Intervention for Major Depression
Lead Sponsor:
Douglas Mental Health University Institute
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
PHASE3
Brief Summary
Transcranial direct current stimulation (tDCS) is a noninvasive method to activate or de-activate neurons in superficial regions of the brain through the induction of weak electric currents in the bra...
Eligibility Criteria
Inclusion
- Presence of a current major depressive disorder (according to the Diagnostic and Statistical Manual, Fourth Edition, Text Revision \[DSM-IV-TR\])
- Baseline score ≥ 13 on the QIDS-C
- Stable medication regimen (\> 4 weeks)
Exclusion
- Psychotic features in the current episode
- Lifetime history of psychotic disorders and/or bipolar I or II disorders
- Substance or alcohol abuse/dependence in the past 6 months
- Lifetime history of a major neurological disease (e.g., Parkinson's, stroke)
- Uncontrolled medical disease (e.g., cardiovascular, renal)
- Pregnancy and/or lactation
- Presence of a specific contraindication for tDCS (e.g., personal history of epilepsy, metallic head implant, cardiac pacemaker)
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01450150
Start Date
January 1 2016
End Date
October 1 2018
Last Update
January 20 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Douglas Mental Health University Institute
Montreal, Quebec, Canada, H4H1R3